iShares MSCI Singapore ETF vs Vital Farms Inc — how do they compare? iShares MSCI Singapore ETF trades at $31.77, while Vital Farms Inc trades at $13.22 (market cap $581.88M). The key difference: iShares MSCI Singapore ETF is trading nearer its 52-week high, Vital Farms Inc nearer its low. Which is the better fit depends on your goals.
| EWS | VITL | |
|---|---|---|
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $32.09 | $52.41 |
52-Week Low | $26.47 | $8.28 |
Market Cap | — | $581.88M |
Enterprise Value | — | $584.69M |
Signals from Pluang's Aura AI — not financial advice
EWS trades at $31.825, up 0.62% with strong technical momentum as moving averages signal bullish alignment. The ETF benefits from Singapore's economic resilience and AI-driven growth narrative, though key financial ratios remain undisclosed. Recent news highlights Singapore's strategic positioning in Asian markets and financial sector strength, with a dividend of $0.52 scheduled for June 2026.
Outlook remains positive given technical strength and regional economic tailwinds, but overbought RSI readings suggest near-term consolidation risk. The concentrated financials exposure (54% of holdings) ties performance to banking sector stability, while AI infrastructure investments offer growth catalysts. Investors should monitor Singapore's economic policies and global market volatility.
Vital Farms (VITL) trades at $13.53, up 3.2% with a bullish technical signal from moving averages and oscillators. The company shows solid fundamentals with a P/E of 13.06, P/S of 0.79, and strong profitability metrics including 35.21% gross margin and 15.44% ROE. Recent quarterly earnings have been mixed with one beat and two misses, while analyst consensus remains positive with 56% buy ratings and a $13.50 price target. However, negative net cash flow and a pending class action lawsuit present notable concerns.
The outlook balances attractive valuation against execution risks. The stock's below-market P/S ratio and strong profitability provide fundamental support, but recent earnings misses, declining projected net income for 2026, and legal uncertainties create headwinds. The bullish technical setup and analyst support suggest potential upside, though investors must weigh these against the company's cash flow challenges and competitive pressures in the natural foods sector.
Trailing returns across standard periods
EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.
Read more on EWS →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →